Abstract:Jonas Lanz and colleagues1Lanz J Kim WK Walther T et al.Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.Lancet. 2019; 394: 1619-1628Summary Full Text Full Text PDF PubMed Scopus (135) Google Scholar compared the effect of a self-expanding valve with a balloon-expandable valve for transcatheter aortic valve replacement (TAVR) in patients with symptomatic severe aortic stenosis. According to the results, the incidence of paravalvular leakage was higher in the group of patients using the self-expanding ACURATE neo device than in the group of patients using the balloon-expandable SAPIEN 3 prosthesis. However, we are concerned that this finding might be at least partly caused by differences in predilatation between the groups. The necessity of dilatation before the TAVR procedure has been debated in recent years. In the randomised trial by Lanz and colleagues,1Lanz J Kim WK Walther T et al.Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.Lancet. 2019; 394: 1619-1628Summary Full Text Full Text PDF PubMed Scopus (135) Google Scholar predilatation was mandatory only for the ACURATE group. However, this requirement might be unnecessary, and an important source of potential bias; for example, in the DIRECT trial,2Toutouzas K Benetos G Voudris V et al.Pre-dilatation versus no pre-dilatation for implantation of a self-expanding valve in all comers undergoing TAVR: the DIRECT trial.JACC Cardiovasc Interv. 2019; 12: 767-777Crossref PubMed Scopus (30) Google Scholar no benefit was found for predilatation among patients with a self-expanding valve. There is controversial evidence regarding the effect of predilatation on paravalvular leak and other clinical outcomes.2Toutouzas K Benetos G Voudris V et al.Pre-dilatation versus no pre-dilatation for implantation of a self-expanding valve in all comers undergoing TAVR: the DIRECT trial.JACC Cardiovasc Interv. 2019; 12: 767-777Crossref PubMed Scopus (30) Google Scholar, 3Deharo P Jaussaud N Grisoli D et al.Impact of direct transcatheter aortic valve replacement without balloon aortic valvuloplasty on procedural and clinical outcomes: insights from the FRANCE TAVI registry.JACC Cardiovasc Interv. 2018; 11: 1956-1965Crossref PubMed Scopus (34) Google Scholar In one prospective study, predilatation was associated with an increased risk of aortic regurgitation.3Deharo P Jaussaud N Grisoli D et al.Impact of direct transcatheter aortic valve replacement without balloon aortic valvuloplasty on procedural and clinical outcomes: insights from the FRANCE TAVI registry.JACC Cardiovasc Interv. 2018; 11: 1956-1965Crossref PubMed Scopus (34) Google Scholar Because the proportion of predilatation was substantially higher in the ACURATE neo group than in the SAPIEN 3 group (88% vs 23%),1Lanz J Kim WK Walther T et al.Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.Lancet. 2019; 394: 1619-1628Summary Full Text Full Text PDF PubMed Scopus (135) Google Scholar it is not certain to what extent the lower risk of moderate or severe aortic regurgitation in the ACURATE group can be explained by the net effect of ACURATE neo versus SAPIEN 3. In conclusion, the potential effect of predilatation is an important issue that needs to be taken into consideration. Controlling for this potential confounder could help to minimise the bias of interpreting the findings in different TAVR systems. We declare no competing interests. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trialTAVR with the self-expanding ACURATE neo did not meet non-inferiority compared to the balloon-expandable SAPIEN 3 device in terms of early safety and clinical efficacy outcomes. An early composite safety and efficacy endpoint was useful in discriminating the performance of different TAVR systems. Full-Text PDF Predilatation and paravalvular leakage risk in TAVR – Authors' replyWe thank Liang Yao and colleagues for their interest in our Article.1 Full-Text PDF

Balloon predilation or direct valve implantation in TAVI for women: Insights from the DIRECTAVI study

Prior Balloon Valvuloplasty Versus Direct Transcatheter Aortic Valve Replacement: Results From the DIRECTAVI Trial

Long-term follow-up of balloon-expandable valves according to the implantation strategy: insight from the DIRECTAVI trial

Prior balloon valvuloplasty versus DIRECT transcatheter Aortic Valve Implantation (DIRECTAVI): study protocol for a randomized controlled trial

The impact of gender on outcomes of transcatheter aortic valve implantation between self-expanding valve and balloon-expandable valve

Transcatheter Aortic Valve Implantation With or Without Predilation: A Meta-Analysis

A sex-specific comparison of valve-in-valve transcatheter aortic valve implantation

Impact of female sex in transcatheter aortic valve replacement. Long-term outcomes

Transcatheter Aortic Valve Replacement in Patients With Small Aortic Annuli: A Propensity-Matched Analysis of Gender-Based Outcomes

Sex-Related Outcomes of Transcatheter Aortic Valve Implantation With Self-Expanding or Balloon-Expandable Valves: Insights from the OPERA-TAVI Registry

Aortic Valve Replacement Versus Balloon Expandable And Self Expandable Transcatheter Aortic Valve Implantation In Low-Risk Patients

Transcatheter Aortic Valve Implantation by Valve Type in Women With Small Annuli: Results From the SMART Randomized Clinical Trial

A Propensity-Matched Analysis of Ultrasound-Guided versus Blind Femoral Artery Puncture in Balloon-Expandable TAVI

Self-Expanding or Balloon-Expandable TAVR in Patients with a Small Aortic Annulus

TAVR-in-TAVR with a balloon-expandable valve for paravalvular leak

Impact of Baseline Left Ventricular Ejection Fraction on Mid-term Outcomes in Women Undergoing Transcatheter Aortic Valve Implantation: Insight from the WIN TAVI Registry

Predilatation and Paravalvular Leakage Risk in TAVR

Computational Study of the Balloon Dilation Steps on Transcatheter Aortic Valve Replacement.

Sex disparities in outcomes of transcatheter aortic valve implantation- a multi-year propensity-matched nationwide study

Sex differences in the outcomes after transcatheter aortic valve replacement with newer generation devices: A meta‐analysis

Clinical impact of sex differences and procedural setting in transcatheter aortic valve implantation